Takeshi Isoyama

<scp>NTRK3</scp> kinase fusions in Spitz tumours

Iwei Yeh, Meng Kian Tee, Thomas Botton et al. · The Journal of Pathology · 2016 · 150 citations · Full text

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models

Ryohei Katayama, Bo Gong, Noriko Togashi et al. · Nature Communications · 2019 · 135 citations · Full text

Intracellular Redistribution of Truncated La Protein Produced by Poliovirus 3C ^pro -Mediated Cleavage

Kazuko Shiroki, Takeshi Isoyama, Shusuke Kuge et al. · Journal of Virology · 1999 · 108 citations · Full text

U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors

Kyriakos P. Papadopoulos, Erkut Borazanci, Alice T. Shaw et al. · Clinical Cancer Research · 2020 · 103 citations · Full text

Nuclear Import of the Yeast AP-1-like Transcription Factor Yap1p Is Mediated by Transport Receptor Pse1p, and This Import Step Is Not Affected by Oxidative Stress

Takeshi Isoyama, Asako Murayama, Akio Nomoto et al. · Journal of Biological Chemistry · 2001 · 79 citations · Full text